MedTrace Logo

Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment

NCT01480700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2013-08-05

No results posted yet for this study

Summary

This study is to determine the impact of the consumption of eggs rich in lutein/zeaxanthin from lucerne protein concentrate and DHA from microalgae on the plasma levels of these compounds but also on the macular pigment optical density, whose elevation may be beneficial in the prevention of Age-related Macular Degeneration (AMD).

Conditions

  • Age-related Macular Degeneration

Interventions

OTHER

Nutritional study

subjects consume 2 eggs per day during 4 months

Sponsors & Collaborators

  • Institut Pasteur de Lille

    lead OTHER

  • Roquette Freres

    collaborator INDUSTRY

  • Sanders

    collaborator UNKNOWN

Principal Investigators

  • Jean-Michel Lecerf, MD · Institut Pasteur de Lille

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480700 on ClinicalTrials.gov